Why the study?
Does amiodarone improve prognosis and systolic function in Japanese patients with severe ischemic heart failure and arrhythmia?
Does amiodarone improve prognosis and systolic function in Japanese patients with severe ischemic heart failure and arrhythmia?
Prognosis remains poor with amiodarone in severe ischemic HF; leaves open optimal arrhythmia strategies for this high-risk group.
Background: Arrhythmias are common in patients with coronary artery disease and heart failure (HF), and confer substantial risks of mortality and morbidity. Amiodarone is an antiarrhythmic drug with potential benefits in HF. The aim of this study was to evaluate the prognosis and change in systolic function of Japanese patients with severe ischemic HF and arrhythmia prescribed amiodarone.
No takes yet. Share an insight, caveat, or question.
Suzuki et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: